Establishment and characterization of a novel Philadelphia-chromosome positive chronic myeloid leukemia cell line, TCC-S, expressing P210 and P190 BCR/ABL transcripts but missing normal ABL gene
Tóm tắt
A novel Philadelphia-chromosome positive (Ph+) cell line, TCC-S, has been established from a patient with Ph+ chronic myeloid leukemia (CML) in the blastic crisis. TCC-S cells were shown to express both P210 and P190 BCR/ABL transcripts by reverse transcriptase-polymerase chain reaction (PCR), although quantitative-PCR revealed that TCC-S cells mainly expressed P210 BCR/ABL transcript. Karyotype analysis revealed several triploid clones which constantly harbored two der(9)del(9)(p12)t(9;22)(q34;q11)s and two del(9)(q21)s. The der(9)del(9)(p12)t(9;22)(q34;q11) is rarely found in other CML cell lines. Moreover, to the best of our knowledge, del(9)(q21) resulting in missing of a restrict region including normal ABL gene has not been found among CML cell lines previously described. Thus, TCC-S cells with only BCR/ABL gene and no normal ABL gene may be a useful tool for functional study of ABL in Ph+ CML.
Tài liệu tham khảo
Kantarjian HM, Deisseroth A, Kurzrock R, et al.: Chronic myelogenous leukemia. Blood. 82: 691–703, 1993.
Drexler HG, Macleod RAF and Uphoff CC: Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leukemia Res. 23: 207–215, 1999.
Deininger MW, Goldman JM and Melo JV: The molecular biology of chronic myeloid leukemia. Blood. 96: 3343–3356, 2000.
Goldman JM and Melo JV: Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 349: 1451–1464, 2003.
Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 88: 2375–2384, 1996.
Saglio G, Guerrasio A, Rosso C, et al.: New type of bcr/abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood. 76: 1819–1824, 1990.
Pane F, Frigeri F, Sidona M, et al.: Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with c3/a2 junction). Blood. 88: 2410–2414, 1996.
Miyawaki S, Tanimoto M, Kobayashi T, et al.: Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia —the JUG —AML —92 Study Japan Adult Leukemia Study Group. Int J Hematol. 70: 87–104, 1999.
Schoumans J, Nielsen K, Jeppesen I, et al.: A comparison of different metaphase CGH methods for the detection of cryptic chromosome aberrations of defined size. Eur J Hum Genet. 2004.
Yanagisawa K, Yamauchi H, Kaneko M, et al.: Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-α. Blood. 91: 641–648, 1998.
Beran M, Pisa P, O’Brien S, et al.: Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Cancer Res. 53: 3603–3610, 1993.
Rhee FV, Hochhaus A, Lin F, et al.: p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood. 87: 5213–5217, 1996.
Oez S, Tittelbach H, Fahsold R, et al.: Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell line. Blood. 76: 578–582, 1990.
Okamura J, Yamada S, Ishii E, et al.: A novel leukemia cell line, MR-87, with positive Philadelphia chromosome and negative breakpoint cluster region rearrangement coexpressing myeloid and early B-cell markers. Blood. 72: 1261–1268, 1988.
Kolomietz E, Al-Maghrabi J, Brennan S, et al.: Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood. 97: 3581–3588, 2001.
Quintas-Cardama A, Kantajian H, Talpaz M, et al.: Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 105: 2281–2286, 2005.